Arkolith/Insider Trading/ATRA/Form 4

Touchon Pascal

President and CEO, DirectorAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Aug 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2024Sell(S)276$6.63$2K70K
Aug 16, 2024Sell(S)3K$6.63$18K70K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-002306) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML